Encouraged by a network of IVD industry leaders, Jeffrey Fleishman founded Plasma Services Group, Inc. in 2004. Drawing from over 35 years of experience in the medical device industry, he used his wealth of knowledge of IVD operational areas to offer his customers innovative production, manufacturing and engineering solutions.
In March 2007, Plasma Services Group expanded its capabilities by opening a production and product testing facility which has evolved into the variety of products and services that we now offer. In late 2007, we established our website to facilitate the purchasing process for human blood products. By providing the most current information about our products and services, we developed cost effective methods for supplying biological materials for research, development and manufacturing. We have also developed a successful national donor recruitment program and are now able to source valuable materials and specific disease states for the ever changing needs of the IVD industry.
By providing quality products and services, and utilizing leading edge technological concepts and methodologies, Plasma Services Group has grown into an industry leader. Our company’s quality policy is essential for securing and maintaining both our customer and supplier relationships. Additionally, we believe that with a thorough understanding of the specific abilities of our suppliers as well as the requirements of our customers, we can continue to exceed expectations. Here at Plasma Services Group, we pride ourselves on providing the highest level of service, support, and integrity. Over the last several years, our company has developed into a thriving, vital organization that now supports the world wide medical device industry.
Within the past year, we established a strategic alliance with Advance BioSource based in Miami – Florida, with donor facilities in Central America. We are proud to announce our affiliation which gives our customers direct access to tropical disease serum such as Chagas and Dengue.
What We Do
Plasma Services Group specializes in sourcing disease state plasma for the in vitro diagnostic industry.
We stock over 500 units of serologically defined plasma with over 35 different specificities at all times. As donors join and leave our plasma collection program, the available disease specificities may vary. Our stock of certain disease states can be limited or in short supply; however, to give our customers the widest selection, we supplement our inventory with samples from other sources.
- We find disease state plasma via a two-fold algorithm: prospective donor screening and active donor recruitment. On average, we screen 75-100 donors per month for up to 25 different diseases. The majority of our materials consist of serologically defined and/or retrospectively collected bleeds.
- To collect human blood products, we utilize FDA registered blood centers in the United States. We also use blood donor centers located outside of the United States to collect some harder to find and/or tropical disease products. All of the donor centers we utilize collect with donor safe guards such as informed consent and viral marker certifications. Our blood products are stored and distributed under our FDA blood establishment registration number 300527238.